Vectorite Biomedical was founded in Taiwan in 2004. It started as a biotech firm, and has focused on the research and commercialization of active cellular immunotherapy to treat cancers among other diseases. For the past 8 years, the company has worked and conducted more than one hundred clinical trials with renowned life science research institutions and hospitals mainly in the greater China region. In Taiwan, Vectorite is widely known and well respected as the leader in the field of active cellular immunotherapy.

Started from 2011, the company has actively been building its immune cell bank business. It provides immune cell banking services which include the collection, processing, testing, cryopreservation and storage of immune cells for our physically healthy customers. The purpose is to preserve and store healthy immune cells when young for potential uses in future immunotherapy treatments.

The firm has since evolved and now has built 2 platforms: one is the Biotech/medical research platform to develop new drugs for a range of cancers; the other is a healthcare services platform: the immune cell bank.